Report Detail
Global (United States, European Union and China) Biologics Market Research Report 2019-2025
- RnM3670212 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Chemical & Material
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
In 2019, the market size of Biologics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologics.
This report studies the global market size of Biologics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biologics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Market Segment by Product Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Market Segment by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biologics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biologics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Biologics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monoclonal Antibodies
- 1.3.3 Vaccines
- 1.3.4 Recombinant Proteins
- 1.3.5 Antisense
- 1.3.6 RNAi
- 1.4 Market Segment by Application
- 1.4.1 Global Biologics Market Share by Application (2019-2025)
- 1.4.2 Infectious Diseases
- 1.4.3 Oncology
- 1.4.4 Immunology
- 1.4.5 Autoimmune Diseases
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Biologics Production Value 2014-2025
- 2.1.2 Global Biologics Production 2014-2025
- 2.1.3 Global Biologics Capacity 2014-2025
- 2.1.4 Global Biologics Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Biologics Market Size CAGR of Key Regions
- 2.2.2 Global Biologics Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Biologics Capacity by Manufacturers
- 3.1.2 Global Biologics Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Biologics Revenue by Manufacturers (2014-2019)
- 3.2.2 Biologics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Biologics Market Concentration Ratio (CR5 and HHI)
- 3.3 Biologics Price by Manufacturers
- 3.4 Key Manufacturers Biologics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Biologics Market
- 3.6 Key Manufacturers Biologics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Monoclonal Antibodies Production and Production Value (2014-2019)
- 4.1.2 Vaccines Production and Production Value (2014-2019)
- 4.1.3 Recombinant Proteins Production and Production Value (2014-2019)
- 4.1.4 Antisense Production and Production Value (2014-2019)
- 4.1.5 RNAi Production and Production Value (2014-2019)
- 4.2 Global Biologics Production Market Share by Type
- 4.3 Global Biologics Production Value Market Share by Type
- 4.4 Biologics Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Biologics Consumption by Application
6 Production by Regions
- 6.1 Global Biologics Production (History Data) by Regions 2014-2019
- 6.2 Global Biologics Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Biologics Production Growth Rate 2014-2019
- 6.3.2 United States Biologics Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Biologics Import & Export
- 6.4 European Union
- 6.4.1 European Union Biologics Production Growth Rate 2014-2019
- 6.4.2 European Union Biologics Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Biologics Import & Export
- 6.5 China
- 6.5.1 China Biologics Production Growth Rate 2014-2019
- 6.5.2 China Biologics Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Biologics Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Biologics Consumption by Regions
- 7.1 Global Biologics Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Biologics Consumption by Type
- 7.2.2 United States Biologics Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Biologics Consumption by Type
- 7.3.2 European Union Biologics Consumption by Application
- 7.4 China
- 7.4.1 China Biologics Consumption by Type
- 7.4.2 China Biologics Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Biologics Consumption by Type
- 7.5.2 Rest of World Biologics Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Eli Lilly & Company
- 8.1.1 Eli Lilly & Company Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Biologics
- 8.1.4 Biologics Product Introduction
- 8.1.5 Eli Lilly & Company Recent Development
- 8.2 Samsung Biologics
- 8.2.1 Samsung Biologics Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Biologics
- 8.2.4 Biologics Product Introduction
- 8.2.5 Samsung Biologics Recent Development
- 8.3 F Hoffman La Roche
- 8.3.1 F Hoffman La Roche Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Biologics
- 8.3.4 Biologics Product Introduction
- 8.3.5 F Hoffman La Roche Recent Development
- 8.4 Celltrion
- 8.4.1 Celltrion Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Biologics
- 8.4.4 Biologics Product Introduction
- 8.4.5 Celltrion Recent Development
- 8.5 Addgene
- 8.5.1 Addgene Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Biologics
- 8.5.4 Biologics Product Introduction
- 8.5.5 Addgene Recent Development
- 8.6 Amgen
- 8.6.1 Amgen Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Biologics
- 8.6.4 Biologics Product Introduction
- 8.6.5 Amgen Recent Development
- 8.7 Abbvie Inc.
- 8.7.1 Abbvie Inc. Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Biologics
- 8.7.4 Biologics Product Introduction
- 8.7.5 Abbvie Inc. Recent Development
- 8.8 Sanofi
- 8.8.1 Sanofi Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Biologics
- 8.8.4 Biologics Product Introduction
- 8.8.5 Sanofi Recent Development
- 8.9 Pfizer Inc.
- 8.9.1 Pfizer Inc. Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Biologics
- 8.9.4 Biologics Product Introduction
- 8.9.5 Pfizer Inc. Recent Development
- 8.10 Merck & Co. Inc.
- 8.10.1 Merck & Co. Inc. Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Biologics
- 8.10.4 Biologics Product Introduction
- 8.10.5 Merck & Co. Inc. Recent Development
- 8.11 Novo Nordisk A/S
- 8.12 Johnson & Johnson Services Inc.
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Biologics Capacity, Production Forecast 2019-2025
- 9.1.2 Global Biologics Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Biologics Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Biologics Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Biologics Production Forecast by Type
- 9.7.2 Global Biologics Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Biologics Sales Channels
- 10.2.2 Biologics Distributors
- 10.3 Biologics Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Biologics. Industry analysis & Market Report on Biologics is a syndicated market report, published as Global (United States, European Union and China) Biologics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
